Abstract
Amiodarone in doses of 200 to 400 mg/day has shown promise in secondary prevention trials for reducing mortality in patients surviving myocardial infarction who have complex ventricular ectopy or nonsustained ventricular tachycardia, or both. In an attempt to explore the lowest dose of amiodarone with antiarrhythmic and hemodynamic activity, we studied 48 patients (mean age 53 +/- 11 years, ejection fraction 23 +/- 9%, clinical heart failure in 85%) with nonsustained ventricular tachycardia. This was a 3-month, randomized, parallel, double-blind pilot study comparing placebo (n = 16) with amiodarone 50 mg/day (n = 15) and 100 mg/day (n = 17). Patients randomized to amiodarone received a mean loading dose of 422 mg/day for the first study week. At the end of the 12 weeks, amiodarone (100 mg) significantly reduced ventricular premature complexes (177 +/- 64 to 98 +/- 38/hour), couplets (8 +/- 3 to 4 +/- 2/hour), and runs of nonsustained ventricular tachycardia (13 +/- 7 to 3 +/- 2/day), all p < 0.01 versus baseline. In addition, 10 of 14 patients taking 100 mg/day had total suppression of nonsustained ventricular tachycardia compared with 4 of 15 taking placebo, p = 0.021. Left ventricular ejection fraction improved by > or = 7% ...Continue Reading
References
Nov 1, 1991·Journal of Clinical Pharmacology·M D Freedman, J C Somberg
Nov 1, 1991·Journal of Clinical Pharmacology·N Z KerinM Rubenfire
Aug 1, 1991·Circulation·J A CairnsR Roberts
Oct 1, 1991·American Heart Journal·J M NicklasB Pitt
Jul 1, 1991·Journal of the American College of Cardiology·J J MahmarianC M Pratt
Dec 1, 1990·Journal of the American College of Cardiology·F BurkartD Burckhardt
May 1, 1987·British Heart Journal·J G ClelandJ T Wilson
Aug 1, 1987·Circulation·J J MahmarianC M Pratt
Jan 1, 1988·Chest·P R KoweyJ L Stohler
Apr 1, 1984·Journal of the American College of Cardiology·D P ZipesJ J Heger
Aug 13, 1983·British Medical Journal·A SamantaA C Burden
Oct 6, 1993·JAMA : the Journal of the American Medical Association·K K TeoC D Furberg
Citations
Mar 31, 2004·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·John J MahmarianTultul Lahiri
Sep 5, 2002·International Journal of Cardiology·Jaffar Ali Raza, Assad Movahed
Oct 22, 1998·International Journal of Cardiology·M PiepoliA J Coats
Sep 1, 1997·Journal of the American College of Cardiology·V R VorperianC T January
Dec 14, 1995·The New England Journal of Medicine·M J SilverE J Topol
May 23, 2006·Journal of Clinical Pathology·W S A SmellieP J Carey
Apr 1, 2000·European Journal of Heart Failure·H NägeleW Rödiger
Oct 20, 1999·Heart·P S MacdonaldD McCaffrey
Jun 26, 2009·British Journal of Clinical Pharmacology·Carmelo Lafuente-LafuenteJean-François Bergmann
Mar 27, 1999·Cardiology Clinics·P M Podrazik, J B Schwartz
Sep 18, 1997·Japanese Circulation Journal·W G Stevenson, M O Sweeney
Dec 10, 2015·The Cochrane Database of Systematic Reviews·Juan Carlos ClaroLuz M Letelier
Nov 11, 1999·Circulation·S J Connolly
Dec 25, 2019·Data in Brief·Morgan K MoroiAndrew J Foy
Oct 24, 2020·Scientific Reports·Eliana SteinbergOfra Benny